Brief: Vivesto, Elevar Seek to Transfer Apealea Rights
Mar 24 (Reuters) - Vivesto and Elevar seek to transfer Elevar’s Apealea rights and obligations to a third party. * A transfer of rights and obligations would require Vivesto’s consent, and no such consent has been given yet * Vivesto will write down balance sheet items preliminary amounting in total to MSEK 190 * Impairment charge and write down have no cash flow impact, nor any other material impact on the company’s financial position
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO